MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Social hindrances for diagnosing Huntington’s disease

    A. Alboudi, P. Sarathchandran, A.B. Almadani (Dubai, United Arab Emirates)

    Objective: The need to differentiate the malingering from real complains Careful history can give a strong clue for the diagnosis Criminals can have diseases also…
  • 2017 International Congress

    Myoclonus in adult onset Huntington’s disease

    S. McAllister, S. Shipley, J. Shah, R. Fekete (New York, NY, USA)

    Objective: We present a case report of adult onset Huntington's disease (HD) with myoclonus as the main clinical feature. Background: Myoclonus is seldom reported as…
  • 2017 International Congress

    Evaluation of serum sestrin protein in Parkinson’s disease: a plausible diagnostic marker

    S. Dey, N. Rai, A. Singh, S. Shekhar, A. Dey (New Delhi, India)

    Objective: In this study, we evaluated the concentrations of sesn1 and sesn2 in the serum of 50 PD patients and 60 elderly controls. Aging is…
  • 2017 International Congress

    Parkinson ‘ s disease and Peripheral Nervous System  : Wax and Waning Non-motor offs and Levodopa-use Topics

    s.g. echebarria mendieta (-, Spain)

    Objective: To relate the non-motor offs theory , sensory signs and levodopa use with neurophysiiology  terms in PD Background: Peripheral Nervous System disease concept in…
  • 2017 International Congress

    Synthesis and pharmacological evaluation of 16-aryldieno steroids as anti-parkinsonian agents in LPS induced Neuroinflammation Model of Rat

    R. Bansal, R. Singh (Chandigarh, India)

    Objective: The present study is aimed at design and synthesis of new therapeutically useful steroidal neuroprotective derivatives as anti-parkinsonian agents. The new 16-aryldieno steroidal derivatives…
  • 2017 International Congress

    Parkinsonism in the very old – A clinicopathological study

    A. Rajput, E. Rajput (Saskatoon, SK, Canada)

    Objective: To identify, spectrum of Parkinson variants, clinical features and course of disease in age > 80 year onset cases. Background: Old age is the…
  • 2017 International Congress

    Metabolomic biomarkers strongly differentiate PD from healthy controls (HCs) in BioFIND study* specimens

    P. LeWitt, J. Li, M. Lu, K.-H. Wu, Y. Zhou, I. Datta, L. Guo, B. Investigators (West Bloomfield, MI, USA)

    Objective: To determine if metabolomic analysis - untargeted profiling of small-molecule (<1.5 kDalton) biochemical constituents - can yield useful diagnostic biomarkers of PD using CSF…
  • 2017 International Congress

    Skin nerve phosphorylated α-synuclein deposits in idiopathic REM sleep behavior disorder.

    E. Antelmi, V. Donadio, G. Plazzi, R. Liguori (Bologna, Italy)

    Objective: Here we tested if p-syn deposits can be detected with the same approach in patients affected with idiopathic RBD (iRBD), as an early histopathological…
  • 2017 International Congress

    Longitudinal study of freezing of gait in patients with Parkinson’s disease

    M. Sawada, K. Wada-Isoe, S. Tagashira, K. Nakashima (Tottori, Japan)

    Objective: We conducted a prospective hospital based cohort study to investigate the incidence of Freezing of gait (FOG) and variables associated with onset of FOG…
  • 2017 International Congress

    Axial signs in early-stage Parkinson’s disease :  an influence of the genotype ?

    G. BAILLE, D. DEVOS, V. HUIN, T. PEREZ, B. SABLONNIERE, L. DEFEBVRE, C. MOREAU (CHRU Lille, France)

    Objective: To assess the association between the genotype and the axial signs. Background: Regarding the onset of axial signs in Parkinson’s Disease (PD), heterogeneity has…
  • « Previous Page
  • 1
  • …
  • 1422
  • 1423
  • 1424
  • 1425
  • 1426
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley